AlloDerm

Key Takeaways

AlloDerm is a processed acellular dermal matrix (ADM) derived from donated human skin tissue, used to support tissue reconstruction in surgical procedures.

A comprehensive AlloDerm consent form documents patient eligibility, contraindications (absolute and relative), informed consent declarations, and post-operative care expectations.

Proper AlloDerm documentation reduces liability, ensures regulatory compliance, and supports accurate procedural billing and clinical outcomes tracking.

Pabau’s digital forms and client record features enable practices to capture, store, and manage AlloDerm consent and procedural documentation securely in one system.

AlloDerm is a sterile tissue product positioned between autogenous grafts and synthetic alternatives in tissue reconstruction. Healthcare professionals performing breast reconstruction, gingival grafting, or soft tissue augmentation rely on AlloDerm to support healing while minimizing donor-site morbidity.

This guide covers the essential elements of an AlloDerm consent form, why thorough documentation matters, and how to implement this template into your clinical workflow using digital consent form capture and patient record management systems.

What is AlloDerm?

AlloDerm is a tissue graft product – specifically, an acellular dermal matrix (ADM) – derived from donated human cadaveric skin. AlloDerm undergoes a proprietary processing technique to remove all cellular components while preserving the extracellular matrix structure (collagen, elastin, and other biologic scaffolding).

The result is a sterile, freeze-dried allograft with a Sterility Assurance Level (SAL) of 10⁻³, suitable for integration into recipient tissues during reconstruction.

First used in burn wound coverage in 1992, AlloDerm expanded into periodontal and plastic surgery applications by 1994, where it became a widely adopted alternative to free autogenous grafts. Unlike donor-site grafting, AlloDerm eliminates the need for a second surgical site, reducing patient morbidity and operative time.

It is manufactured by LifeCell Corporation and distributed through BioHorizons and Allergan Aesthetics. Proper clinical documentation of AlloDerm use is essential for regulatory compliance, insurance reimbursement, and liability protection.

How to use the AlloDerm consent form template

The AlloDerm consent form template guides clinicians through five core operational steps to ensure comprehensive patient screening and informed decision-making before the procedure.

1. Patient demographics and contact information – Capture patient name, date of birth, medical record number, and contact details. This establishes the baseline clinical record and ensures proper patient identification throughout the consent process.
2. Absolute contraindications screening – Review and document absolute contraindications to AlloDerm use, including known hypersensitivity to human tissue or processing agents, active systemic or local infection, pregnancy (for certain applications), and inadequate tissue recipient bed. Patients with any absolute contraindication are ineligible for the procedure.
3. Relative contraindications assessment – Document relative contraindications such as uncontrolled diabetes (ICD-10 E11.9), immunosuppression (ICD-10 D84.9), concurrent use of anticoagulants, and smoking history (ICD-10 F17.210). These require clinical judgment and may necessitate additional pre-operative assessment, modified post-operative protocols, or alternative treatment approaches.
4. Informed consent declarations – Present numbered consent statements covering AlloDerm origin (acellular allograft from screened tissue donors), integration timeline (typically 4-12 weeks depending on location), potential outcomes (improved tissue support, reduced donor morbidity), and realistic limitations (AlloDerm is supportive, not generative, and outcomes vary by anatomy and patient factors).
5. Post-operative care instructions and follow-up scheduling – Detail immobilization duration, activity restrictions, wound care, sign/symptom monitoring, and scheduled follow-up appointments. Clear expectations reduce anxiety and support treatment adherence.

Once completed, store the signed consent form securely in the patient’s electronic client record, linked to the procedural documentation and operative notes. This integrated approach ensures comprehensive audit trails and streamlines compliance reporting.

Who is the AlloDerm template helpful for?

The AlloDerm template is designed for multiple healthcare specialties that incorporate tissue grafting into their scope:

• Plastic surgeons and surgical centers performing breast reconstruction, facial augmentation, scar revision, and soft tissue repair. AlloDerm provides structural support during immediate or delayed reconstruction, particularly for post-mastectomy and post-injury cases.
• Periodontists and oral surgeons addressing gingival recession, periodontal defects, and esthetic gum contouring. AlloDerm supports keratinized tissue gain and reduces donor-site morbidity compared to free gingival grafts.
• Dermatologists in surgical practices performing complex skin reconstruction, burn coverage, and tissue augmentation as part of a comprehensive dermatologic surgery program.
• Regenerative medicine and aesthetic practices offering tissue regeneration and augmentation therapies that incorporate AlloDerm or similar acellular matrix products as part of a multi-modality treatment plan.

Any plastic surgery practice or specialty practice using AlloDerm must maintain standardized, comprehensive consent documentation. This template accelerates the process while ensuring legal defensibility and clinical rigor.

Practices building out a full consent and aftercare library often pair this template with others covering adjacent procedures, such as a botulinum toxin consent form for injectables, a wisdom teeth removal aftercare template for oral surgery cases, or a sclerotherapy treatment template for vascular procedures.

Benefits of using an AlloDerm consent form template

Regulatory and legal compliance: A structured consent form demonstrates informed patient decision-making and adherence to standard-of-care documentation requirements. It reduces liability exposure in disputes or adverse outcome scenarios by creating a contemporaneous written record of patient education and acknowledgment.

Clinical workflow efficiency: A template eliminates repetitive handwriting or ad-hoc form creation. Staff can capture patient information, contraindication screening, and consent signatures in minutes using digital form workflows. This increases throughput during busy surgical schedules without sacrificing accuracy.

Standardized patient communication: Identical consent language across all AlloDerm procedures ensures consistent patient education and reduces variability in informed consent quality. Patients receive the same core information regardless of which clinician obtains the consent.

Documentation clarity for billing and coding: A completed AlloDerm consent form provides clear evidence of the procedural intent (tissue reconstruction vs. augmentation), which supports accurate CPT coding (e.g., CPT 15002 for skin grafting or CPT 15272 for skin substitute grafts) and HCPCS coding (e.g., HCPCS C1762 for human connective tissue).

It documents the specific graft material (AlloDerm vs. autogenous vs. other ADM), essential for claim submission and payer audits.

Audit and compliance readiness: Organized, signed consent forms streamline internal audits, regulatory inspections (CMS, state health boards), and insurance credentialing reviews. A centralized digital archive ensures rapid retrieval during compliance inquiries.

When integrated with a dermatology or surgical practice management system, the AlloDerm template becomes part of a unified clinical workflow that links consent, clinical notes, imaging, operative reports, and follow-up assessments in one record.

Implementing AlloDerm documentation in your practice

Successful AlloDerm documentation begins with clinical documentation best practices. Assign one staff member to oversee template implementation and ensure all clinicians understand the contraindication criteria and consent language before launch.

Train intake staff to screen absolute contraindications during the initial consultation. For patients with relative contraindications, document the clinical decision rationale (e.g., “diabetes controlled with insulin (ICD-10 Z79.4); patient education provided regarding delayed healing risk”) in the chart. This demonstrates thorough patient assessment and informed decision-making.

Capture the completed form in your patient portal or electronic record system so that operative staff can verify consent before the procedure begins. Link the consent form to the operative note and post-operative instructions for a complete audit trail. Regular template audits (quarterly or semi-annually) ensure ongoing compliance and identify any missing documentation patterns.

AlloDerm safety, contraindications, and regulatory oversight

AlloDerm is regulated by the FDA as a human-cell tissue product (HCT/P) under 21 CFR 1271 and approved for repair or replacement of damaged or inadequate integumental tissue. The manufacturing process includes viral and bacterial screening of donor tissue and terminal sterilization to achieve a SAL of 10⁻³, making transmission of infectious disease extremely unlikely.

The American Association of Tissue Banks (AATB) sets standards for tissue collection, processing, and quality assurance. When selecting an AlloDerm supplier, verify AATB accreditation and review donor screening protocols. This reinforces patient safety messaging in your consent form.

Absolute contraindications include known hypersensitivity, active infection at the graft site, pregnancy (context-dependent), and severely compromised tissue beds. Relative contraindications require clinician judgment and may alter technique or post-operative management.

Informed consent best practices require that patients understand both the benefits of AlloDerm (reduced donor morbidity, structural support) and realistic limitations (outcomes vary, integration is not instantaneous, and alternative options exist).

Post-operative complications are rare but may include graft non-integration, infection, or delayed healing in immunocompromised patients. Documentation of relative contraindications and modified post-operative protocols for at-risk patients demonstrates standard-of-care compliance.

Consent form documentation and regulatory alignment

Your AlloDerm consent form should explicitly address FDA-approved indications: repair or replacement of damaged or inadequate integumental (skin or skin-like) tissue. Avoid language implying regeneration or “replacement with living tissue” – AlloDerm is supportive, not restorative of original function.

Use clear, patient-friendly language explaining that AlloDerm provides a scaffold and that the patient’s own healing processes integrate it over weeks to months.

Include a section documenting tissue bank sourcing (e.g., “Your AlloDerm graft comes from LifeCell Corporation, which sources donor tissue from screened, consented cadaveric donors and processes it according to FDA regulations and AATB standards”). This transparency builds patient confidence and demonstrates regulatory awareness.

For reimbursement, ensure the consent form specifies the CPT code being billed for the procedure (e.g., CPT 15777 for acellular dermal matrix implantation in breast/trunk reconstruction, or the applicable dental D-code for periodontal grafting) and note any pre-authorization requirements.

Some payers deny AlloDerm as non-medically necessary for elective reconstruction; a documented informed consent explaining patient choice and clinical rationale supports appeal submissions if needed.

Integrating AlloDerm documentation with practice management

When you move from paper to regenerative medicine documentation systems, your AlloDerm template workflow becomes seamless. Capture consent during the pre-operative visit, auto-populate patient demographics, and flag relative contraindications for clinician review. Store signed forms in the patient chart, linked to pre- and post-operative instructions.

Use your system’s task and reminder features to schedule post-operative follow-ups documented in the consent form. Audit trails automatically track who completed the form, when, and any subsequent modifications – critical for compliance audits and liability defense. For a broader comparison of platforms that support this kind of automation, see our review of clinical documentation software.

This integrated approach – combining clinical documentation, consent capture, and post-operative tracking in one system – reduces administrative overhead, ensures consistency across your team, and protects your practice’s reputation and revenue.

Conclusion

A standardized AlloDerm consent form protects patients and practices alike: it documents contraindication screening, sets realistic expectations for integration and outcomes, and creates the paper trail regulators and payers expect. Building this template into your intake and clinical documentation workflow reduces liability exposure, speeds up busy surgical schedules, and keeps consent, procedural notes, and billing codes aligned in one record.

Expert picks

Continue your research

Reconstructing after mastectomy or implant revision? Our breast augmentation consent form covers implant-specific disclosures that pair with AlloDerm-supported reconstruction cases.

Building out a full consent library? The dermal filler consent form template shows how consent structure adapts for minimally invasive aesthetic treatments.

Planning to add AlloDerm procedures to a cosmetic surgery practice? See our guide on opening a cosmetic surgery practice for compliant setup and documentation steps.

Frequently asked questions